biotech

Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Tim Springer
Harvard
biotech
R&D
Flag link:
3 Key Biotech Trends for 2023 And Beyond
3 Key Biotech Trends for 2023 And Beyond
Motley Fool
biotech
collaboration
artificial intelligence
clinical trials
drug development
Flag link:
So you think you can go public? Few biotechs dance with Wall Street
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
Flag link:
After a record run, fewer biotechs are going public. Here’s how they’re performing.
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
biotech
IPOs
Flag link:
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Biotechs see 'staggering' 87% rise in layoffs during Q1, on pace to overtake 2022
Fierce Biotech
layoffs
biotech
Flag link:
Biotech layoffs gather pace as industry downturn persists
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Flag link:
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling
BioSpace
biotech
FDA
Texas
legal
mifepristone
abortion pill
Flag link:
Biotech leaders 'cannot stay quiet' as judge blocks abortion pill approval
Biotech leaders 'cannot stay quiet' as judge blocks abortion pill approval
Fierce Biotech
biotech
FDA
legal
abortion pill
mifepristone
Flag link:
Floating biotechs prompt tiny sparks of hope
Floating biotechs prompt tiny sparks of hope
EP Vantage
IPOs
biotech
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Flag link:
A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab
A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab
BioPharma Dive
startups
biotech
Beam Therapeutics
Prime Medicine
Resonance Medicine
David Liu
Flag link:
As market stays cold, biotechs continue to cut programs, trials and staff
As market stays cold, biotechs continue to cut programs, trials and staff
Endpoints
biotech
layoffs
Freeline Therapeutics
Oncternal
Tonix Pharmaceuticals
VBI Vaccines
Flag link:
Record growth in U.S. life sciences real estate footprint
Record growth in U.S. life sciences real estate footprint
Axios
life sciences
R&D
biotech
Flag link:
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Fierce Biotech
Cure Ventures
biotech
funding
venture capital
Flag link:
US government announces ambitions for biomanufacturing
US government announces ambitions for biomanufacturing
Biopharma Reporter
federal government
biotech
drug manufacturing
Flag link:
Top biotech licensing deals of Q1 2023
Top biotech licensing deals of Q1 2023
BioSpace
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Flag link:
Biotech heads towards big catalysts
Biotech heads towards big catalysts
EP Vantage
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Flag link:
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
Biopharma Reporter
biotech
UK
innovation
R&D
Flag link:
Europe rues SVB loss as a cornerstone life science supporter
Europe rues SVB loss as a cornerstone life science supporter
EP Vantage
SVB
biotech
life sciences
Europe
Flag link:
Silicon Valley Bank: biopharma’s latest crisis
Silicon Valley Bank: biopharma’s latest crisis
EP Vantage
SVB
biotech
Flag link:
‘What a mess’: How biotech startups grappled with SVB’s collapse
‘What a mess’: How biotech startups grappled with SVB’s collapse
BioPharma Dive
biotech
startups
SVB
Flag link:

Pages